Stromal Tumor Infiltrating Lymphocytes (sTIL) as an Independent Predictor of Pathologic Response to Neadjuvant Chemotherapy in Breast Cancer in Indonesia: A Hospital-based Study.

Published in: Asian Pacific journal of cancer prevention : APJCP (2022)

sTIL intensity was mostly low in Indonesian breast cancer patient. However, it can predict neoadjuvant chemotherapy response, with 0.07 lower RCB score for every 1% increase of sTIL intensity.

Keyphrases

neoadjuvant chemotherapy
locally advanced
rectal cancer
lymph node
sentinel lymph node
squamous cell carcinoma
high intensity
radiation therapy
healthcare
bone marrow
case report
peripheral blood
breast cancer risk